[1] Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2015 Annual Data Report: Liver. Am J Transplant,2017,17(Suppl 1):174-225.
[2] Chalasani N, Younossi Z, Lavine JF, et al. The Diagnosis and Management of Non Alcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Disease. Hepatology,2017,67:328-357.
[3] Younossi Z, Blisset D, Blisset R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology,2016,64:1577-1586.
[4] Spengler EK, O’Leary JG, Te HS, et al. Liver transplantation in the obese cirrhotic patient. Transplantation,2017,101:2288-2296.
[5] Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and nonalcoholic steatohepatitis-related liver trans-plantation waitlist additions in the United States. Hepatology, 2019,71:487-495. |
